The results failed to show any significant association between human insulin use and risk of developing thyroid cancer, even at higher doses (Tseng, 2014b)
Additionally, data from ACCORD trial demonstrated that intensive blood pressure management reduced the risk of CAN by 25%
The FDA warns that these products may be at different dosage levels, increasing the risk of dosing errors
Ethics declarations Funding This work was supported by the National Natural Science Foundation of China (82103475), Hebei Province Natural Science Foundation (H2023307028, H2024206056), the Medical Science Research Project of Hebei Provincial Health Commission (20240370), Hebei Province Medical Adaptation Technology Tracking Project (GZ2024002), and Hebei Province Government-Funded Clinical Medicine Excellent Talent Training Program (ZF2025013)
We are conveniently located at 7510 North Forest Drive North Charleston, SC 29420